rdf:type |
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0021107,
umls-concept:C0036186,
umls-concept:C0038257,
umls-concept:C0221198,
umls-concept:C0332835,
umls-concept:C0549178,
umls-concept:C0814225,
umls-concept:C1517942,
umls-concept:C1527362,
umls-concept:C1707455,
umls-concept:C2348535
|
pubmed:issue |
2
|
pubmed:dateCreated |
2011-2-25
|
pubmed:databankReference |
|
pubmed:abstractText |
This study sought to report the long-term outcomes after drug-eluting stent (DES) implantation in saphenous vein graft (SVG) lesions in the SOS (Stenting of Saphenous Vein Grafts) trial.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1876-7605
|
pubmed:author |
pubmed-author:Abdel-karimAbdul-rahman RAR,
pubmed-author:AddoTayoT,
pubmed-author:BanerjeeSubhashS,
pubmed-author:BergerPeterP,
pubmed-author:BissettJoseph KJK,
pubmed-author:BrilakisEmmanouil SES,
pubmed-author:FasseasPanayotisP,
pubmed-author:HaagenDonaldD,
pubmed-author:KarBiswajitB,
pubmed-author:KaryofillisPanagiotisP,
pubmed-author:LichtenwalterChristopherC,
pubmed-author:ObelOwenO,
pubmed-author:RanganBavana VBV,
pubmed-author:RoesleMicheleM,
pubmed-author:RossenJamesJ,
pubmed-author:SachdevaRajeshR,
pubmed-author:SaeedBilalB,
pubmed-author:VoudrisVassilios VVV,
pubmed-author:de LemosJames AJA
|
pubmed:copyrightInfo |
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
176-82
|
pubmed:meshHeading |
pubmed-meshheading:21349456-Aged,
pubmed-meshheading:21349456-Angioplasty, Balloon, Coronary,
pubmed-meshheading:21349456-Cardiovascular Agents,
pubmed-meshheading:21349456-Coronary Angiography,
pubmed-meshheading:21349456-Coronary Artery Bypass,
pubmed-meshheading:21349456-Drug-Eluting Stents,
pubmed-meshheading:21349456-Female,
pubmed-meshheading:21349456-Graft Occlusion, Vascular,
pubmed-meshheading:21349456-Humans,
pubmed-meshheading:21349456-Kaplan-Meier Estimate,
pubmed-meshheading:21349456-Male,
pubmed-meshheading:21349456-Metals,
pubmed-meshheading:21349456-Middle Aged,
pubmed-meshheading:21349456-Myocardial Infarction,
pubmed-meshheading:21349456-Paclitaxel,
pubmed-meshheading:21349456-Proportional Hazards Models,
pubmed-meshheading:21349456-Prosthesis Design,
pubmed-meshheading:21349456-Risk Assessment,
pubmed-meshheading:21349456-Risk Factors,
pubmed-meshheading:21349456-Saphenous Vein,
pubmed-meshheading:21349456-Single-Blind Method,
pubmed-meshheading:21349456-Stents,
pubmed-meshheading:21349456-Thrombosis,
pubmed-meshheading:21349456-Time Factors,
pubmed-meshheading:21349456-Treatment Outcome,
pubmed-meshheading:21349456-United States
|
pubmed:year |
2011
|
pubmed:articleTitle |
Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
|
pubmed:affiliation |
Department of Cardiovascular Diseases, Veteran Affairs North Texas Healthcare System, Dallas, Texas, USA. esbrilakis@yahoo.com
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, Non-P.H.S.,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|